Italia markets closed

BMY Sep 2024 55.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,1600-0,0100 (-5,88%)
In data: 09:30AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,1700
Aperto0,1600
Denaro0,1400
Lettera0,1800
Prezzo d'esercizio55,00
Scadenza2024-09-20
Min-Max giorno0,1600 - 0,1800
Contratto - Min-MaxN/D
Volume6
Open Interest3,72k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri